FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lieven Stuyver

Research Profile

Living Beings

Physiology

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Polymerase Chain Reaction

Co-author Network

Publications

TOP 3
Susan C Aitken; Sheila Balinda; Michelle Bronze; Cissy Kityo; Tobias F Rinke de Wit; Kim Steegen; Wendy Stevens; Lieven Stuyver; Carole L Wallis; Rob Schuurman
A Pragmatic Approach to HIV-1 Drug Resistance Determination in Resource-Limited Settings by Use of a Novel Genotyping Assay Targeting the Reverse Transcriptase-Encoding Region Only.
Mahir S Ozdemir; Marcin Pawlak; Dirk Roymans; Lieven Stuyver; Koen Vanhoutte; Hugo Bohets; Kristien Bonroy; Marcin Marczak; Eric Bakker
A label-free potentiometric sensor principle for the detection of antibody-antigen interactions.
Peter Messiaen; Lieven Stuyver; Kim Thys; Veerle Van Eygen; Ina Vandenbroucke; Chris Verhofstede; Dirk Vogelaers; Bart Winters; Jeroen Aerssens; Sylvie Dinakis; Linos Vandekerckhove
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lieven Stuyver (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susan C Aitken; Sheila Balinda; Michelle Bronze; Cissy Kityo; Tobias F Rinke de Wit; Kim Steegen; Wendy Stevens; Lieven Stuyver; Carole L Wallis; Rob Schuurman
A Pragmatic Approach to HIV-1 Drug Resistance Determination in Resource-Limited Settings by Use of a Novel Genotyping Assay Targeting the Reverse Transcriptase-Encoding Region Only.
Journal of clinical microbiology 2013;51(6):1757-61.
2013: Mahir S Ozdemir; Marcin Pawlak; Dirk Roymans; Lieven Stuyver; Koen Vanhoutte; Hugo Bohets; Kristien Bonroy; Marcin Marczak; Eric Bakker
A label-free potentiometric sensor principle for the detection of antibody-antigen interactions.
Analytical chemistry 2013;85(9):4770-6.
2012: Peter Messiaen; Lieven Stuyver; Kim Thys; Veerle Van Eygen; Ina Vandenbroucke; Chris Verhofstede; Dirk Vogelaers; Bart Winters; Jeroen Aerssens; Sylvie Dinakis; Linos Vandekerckhove
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.
Virology 2012;426(1):7-11.
2012: Daniele Armenia; Bianca Bruzzone; Jeroen Aerssens; Andrea Antinori; Valeria Cento; Roberta D'Arrigo; Lavinia Fabeni; Sergio Lo Caputo; Valeria Micheli; Pasquale Narciso; Carlo Federico Perno; Giuliano Rizzardini; Fernanda Scopelliti; Lieven Stuyver; Valerio Tozzi; Herwig Van Marck; Liesbeth Van Wesenbeeck; Ina Vandenbroucke; Francesca Ceccherini-Silberstein
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing.
The Journal of infectious diseases 2012;205(4):557-67.
2011: Ann D Kwong; Isabel Najera; Jill Bechtel; Scott Bowden; Joseph Fitzgibbon; Patrick Harrington; Dale Kempf; Tara L Kieffer; Diana Koletzki; George Kukolj; Sharlene Lim; Tami Pilot-Matias; Kai Lin; Nina Mani; Hongmei Mo; Jules O'Rear; Michael Otto; Neil Parkin; Jean-Michel Pawlotsky; Chris Petropoulos; Gaston Picchio; Robert Ralston; Jacqueline D Reeves; Robert T Schooley; Scott Seiwert; David Standring; Lieven Stuyver; James Sullivan; Veronica Miller
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Gastroenterology 2011;140(3):755-60.
2011: Linos Vandekerckhove; Chris Verhofstede; Els Demecheleer; Stephane De Wit; Eric Florence; Katrien Fransen; Michel Moutschen; Wendy Mostmans; Kabamba Kabeya; Nicola Mackie; Jean Plum; Dolores Vaira; Kurt Van Baelen; Ina Vandenbroucke; Veerle Van Eygen; Herwig Van Marck; Dirk Vogelaers; Anna Maria Geretti; Lieven Stuyver
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.
The Journal of antimicrobial chemotherapy 2011;66(2):265-72.
2010: Diana Koletzki; Stéphanie Dumont; Hans Vermeiren; Bart Fevery; Pieter De Smet; Lieven Stuyver
Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(8):1095-102.
2010: Ina Vandenbroucke; Herwig Van Marck; Wendy Mostmans; Veerle Van Eygen; Evelien Rondelez; Kim Thys; Kurt Van Baelen; Katrien Fransen; Dolores Vaira; Kabamba Kabeya; Stephane De Wit; Eric Florence; Michel Moutschen; Linos Vandekerckhove; Chris Verhofstede; Lieven Stuyver
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays.
AIDS research and therapy 2010;7():4.
2009: David Nauwelaers; Leen Vijgen; Claire Atkinson; Alison Todd; Anna Maria Geretti; Marc Van Ranst; Lieven Stuyver
Development of a real-time multiplex RSV detection assay for difficult respiratory samples, using ultrasone waves and MNAzyme technology.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;46(3):238-43.
2009: Chris Verhofstede; Linos Vandekerckhove; Veerle Van Eygen; Els Demecheleer; Ina Vandenbroucke; Bart Winters; Jean Plum; Dirk Vogelaers; Lieven Stuyver
CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA.
Journal of acquired immune deficiency syndromes (1999) 2009;50(2):126-36.
2009: Diana Koletzki; Stéphanie Dumont; Hans Vermeiren; Paula Peixe; Jaime Nina; Ricardo J Camacho; Lieven Stuyver
Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal.
Archives of virology 2009;154(1):127-32.
2008: Kristen Chalmet; Filip Van Wanzeele; Els Demecheleer; Kenny Dauwe; Jolanda Pelgrom; Bea Van Der Gucht; Dirk Vogelaers; Jean Plum; Lieven Stuyver; Linos Vandekerckhove; Chris Verhofstede
Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
Virology 2008;379(2):213-22.
2008: Kurt Van Baelen; Veerle Van Eygen; Evelien Rondelez; Lieven Stuyver
Clade-specific HIV-1 integrase polymorphisms do not reduce raltegravir and elvitegravir phenotypic susceptibility.
AIDS (London, England) 2008;22(14):1877-80.
2008: Carmen de Mendoza; Kurt Van Baelen; Eva Poveda; Evelien Rondelez; Natalia Zahonero; Lieven Stuyver; Carolina Garrido; Jorge Villacian; Vincent Soriano
Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):241-4.
2008: Ina Vandenbroucke; Veerle Van Eygen; Evelien Rondelez; Hans Vermeiren; Kurt Van Baelen; Lieven Stuyver
Minor Variant Detection at Different Template Concentrations in HIV-1 Phenotypic and Genotypic Tropism Testing.
The open virology journal 2008;2():8-14.
2007: Kurt Van Baelen; Ina Vandenbroucke; Evelien Rondelez; Veerle Van Eygen; Hans Vermeiren; Lieven Stuyver
HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Journal of virological methods 2007;146(1-2):61-73.
2007: Eisuke Murakami; Haiying Bao; Mangala Ramesh; Tamara R McBrayer; Tony Whitaker; Holly M Micolochick Steuer; Ray F Schinazi; Lieven Stuyver; Aleksandr Obikhod; Michael J Otto; Phillip A Furman
Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
Antimicrobial agents and chemotherapy 2007;51(2):503-9.
2007: AJR Chun; Peiyuan Wang; Abdalla Hassan; Jinfa Du; Phillip M Tharnish; Eisuke Murakami; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Kyoichi A Watanabe
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents.
Nucleosides, nucleotides & nucleic acids 2007;26(1):83-97.
2006: Michel Rosenheim; Jean-François Cadranel; Lieven Stuyver; Richard Dorent; Franck Golliot; Pascal Astagneau; Vincent Di Martino; Annick Delcourt; Iradj Gandjbakhch; Jean-Marie Huraux; Françoise Lunel
Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy.
Gastroentérologie clinique et biologique 2006;30(11):1274-80.
2006: Yoann Morice; Jean-François Cantaloube; Stéphanie Beaucourt; Laetitia Barbotte; Sija De Gendt; Fernando Lopes Goncales; Lesley Butterworth; Graham Cooksley; Robert G Gish; Michel Beaugrand; Fabian Fay; Oscar Fay; Jorge E Gonzalez; Regina M B Martins; Daniel Dhumeaux; Bart Vanderborght; Lieven Stuyver; Erwin Sablon; Xavier de Lamballerie; Jean-Michel Pawlotsky
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
Journal of medical virology 2006;78(10):1296-303.
2006: Laurence Vergne; Lieven Stuyver; Margriet Van Houtte; Christelle Butel; Eric Delaporte; Martine Peeters
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):43-9.
2006: Jeremy L Clark; J Christian Mason; Laurent Hollecker; Lieven Stuyver; Phillip M Tharnish; Tamara R McBrayer; Michael J Otto; Phillip A Furman; Ray F Schinazi; Kyoichi A Watanabe
Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Bioorganic & medicinal chemistry letters 2006;16(6):1712-5.
2006: Lieven Stuyver; Tamara R McBrayer; Phillip M Tharnish; Jeremy Clark; Laurent Hollecker; Stefania Lostia; Tammy Nachman; Jason Grier; Matthew A Bennett; Meng-Yu Xie; Ray F Schinazi; John D Morrey; Justin L Julander; Phillip A Furman; Michael J Otto
Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication.
Antiviral chemistry & chemotherapy 2006;17(2):79-87.
2005: Peiyuan Wang; Jinfa Du; Suguna Rachakonda; AJR Chun; Phillip M Tharnish; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Kyoichi A Watanabe
Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives.
Journal of medicinal chemistry 2005;48(20):6454-60.
2005: Peter Simmonds; Jens Bukh; Christophe Combet; Gilbert Deléage; Nobuyuki Enomoto; Stephen Feinstone; Phillippe Halfon; Geneviève Inchauspé; Carla Kuiken; Geert Maertens; Masashi Mizokami; Donald G Murphy; Hiroaki Okamoto; Jean-Michel Pawlotsky; François Penin; Erwin Sablon; Tadasu Shin-i; Lieven Stuyver; Heinz-Jürgen Thiel; Sergei Viazov; Amy J Weiner; Anders Widell
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Hepatology (Baltimore, Md.) 2005;42(4):962-73.
2005: Jeremy L Clark; Laurent Hollecker; J Christian Mason; Lieven Stuyver; Phillip M Tharnish; Stefania Lostia; Tamara R McBrayer; Ray F Schinazi; Kyoichi A Watanabe; Michael J Otto; Phillip A Furman; Wojciech J Stec; Steven E Patterson; Krzysztof W Pankiewicz
Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Journal of medicinal chemistry 2005;48(17):5504-8.
2005: Junxing Shi; Jinfa Du; Tianwei Ma; Krzysztof W Pankiewicz; Steven E Patterson; Phillip M Tharnish; Tamara R McBrayer; Lieven Stuyver; Michael J Otto; Chung (David) K. Chu; Ray F Schinazi; Kyoichi A Watanabe
Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system.
Bioorganic & medicinal chemistry 2005;13(5):1641-52.
2005: Abdalla E A Hassan; Peiyuan Wang; Tamara R McBrayer; Phillip M Tharnish; Lieven Stuyver; Michael J Otto; Kyoichi A Watanabe; Ray F Schinazi
Synthesis and anti-HCV activity of N9,5'-cyclo-3-(beta-D-ribofuranosyl)-8-azapurin-2-one derivatives.
Nucleosides, nucleotides & nucleic acids 2005;24(10-12):1531-42.
2005: Jinfa Du; Laurent Hollecker; Junxing Shi; AJR Chun; Kyoichi A Watanabe; F Schinazi Raymond; Tammy Y Nachman; Stefania Lostia; Lieven Stuyver; Michael J Otto
N4-hydroxycytosine dioxolane nucleosides and their activity against hepatitis B virus.
Nucleosides, nucleotides & nucleic acids 2005;24(8):1209-14.
2005: Abdalla E A Hassan; Peiyuan Wang; Tamara R McBrayer; Phillip M Tharnish; Lieven Stuyver; Ray F Schinazi; Michael J Otto; Kyoichi A Watanabe
Synthesis and anti-hepatitis C virus activity of nucleoside derivatives of N3, 5'-anhydro-4-(beta-D-ribofuranosyl)-8-aza-purin-2-ones.
Nucleosides, nucleotides & nucleic acids 2005;24(5-7):961-4.
2005: Peiyuan Wang; Laurent Hollecker; Krzysztof W Pankiewicz; Steven E Patterson; Tony Whitaker; Tamara R McBrayer; Phillip M Tharnish; Lieven Stuyver; Ray F Schinazi; Michael J Otto; Kyoichi A Watanabe
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agents.
Nucleosides, nucleotides & nucleic acids 2005;24(5-7):957-60.
2005: Junxing Shi; Jinfa Du; Tianwei Ma; Krzysztof W Pankiewicz; Steven E Patterson; Abdalla E A Hassan; Phillip M Tharnish; Tamara R McBrayer; Stefania Lostia; Lieven Stuyver; Kyoichi A Watanabe; Chung (David) K. Chu; Ray F Schinazi; Michael J Otto
Synthesis and in vitro anti-HCV activity of beta-D- and 1-2'-deoxy-2'-fluororibonucleosides.
Nucleosides, nucleotides & nucleic acids 2005;24(5-7):875-9.
2004: Brenda I Hernandez-Santiago; Thierry Beltran; Lieven Stuyver; Chung (David) K. Chu; Ray F Schinazi
Metabolism of the anti-hepatitis C virus nucleoside beta-D-N4-hydroxycytidine in different liver cells.
Antimicrobial agents and chemotherapy 2004;48(12):4636-42.
2004: Peiyuan Wang; Laurent Hollecker; Krzysztof W Pankiewicz; Steven E Patterson; Tony Whitaker; Tamara R McBrayer; Phillip M Tharnish; Robert W Sidwell; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Kyoichi A Watanabe
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity.
Journal of medicinal chemistry 2004;47(24):6100-3.
2004: Lieven Stuyver; Tamara R McBrayer; Dirk Schürmann; Irena Kravec; Amanda Beard; Leanne Cartee; Ray F Schinazi; Abel De La Rosa; Robert L Murphy; Michael J Otto
Potent antiviral effect of reverset in HIV-1-infected adults following a single oral dose.
Antiviral therapy 2004;9(4):529-36.
2004: Krzysztof W Pankiewicz; Steven E Patterson; Paul L Black; Hiremagalur N Jayaram; Dipesh Risal; Barry M Goldstein; Lieven Stuyver; Ray F Schinazi
Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target.
Current medicinal chemistry 2004;11(7):887-900.
2004: Jinfa Du; Steven Patterson; Junxing Shi; AJR Chun; Lieven Stuyver; Kyoichi A Watanabe
Synthesis of 5'-C-methyl-1',3'-dioxolan-4'-yl nucleosides.
Bioorganic & medicinal chemistry letters 2004;14(5):1243-5.
2004: Lieven Stuyver; Tamara R McBrayer; Tony Whitaker; Phillip M Tharnish; Mangala Ramesh; Stefania Lostia; Leanne Cartee; Junxing Shi; Ann Hobbs; Ray F Schinazi; Kyoichi A Watanabe; Michael J Otto
Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine.
Antimicrobial agents and chemotherapy 2004;48(2):651-4.
2004: Laurent Hollecker; Hyunah Choo; Youhoon Chong; Chung (David) K. Chu; Stefania Lostia; Tamara R McBrayer; Lieven Stuyver; J Christian Mason; Jinfa Du; Suguna Rachakonda; Junxing Shi; Ray F Schinazi; Kyochi A Watanabe
Synthesis of beta-enantiomers of N4-hydroxy-3'-deoxypyrimidine nucleosides and their evaluation against bovine viral diarrhoea virus and hepatitis C virus in cell culture.
Antiviral chemistry & chemotherapy 2004;15(1):43-55.
2003: Charlotte L Cameron-Wilson; Peter Muir; Anna L Ballard; Sally A Corden; Elizabeth H Boxall; Erwin Sablon; Lieven Stuyver
Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers.
Journal of virological methods 2003;114(1):97-103.
2003: Youhoon Chong; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Chung (David) K. Chu
Mechanism of antiviral activities of 3'-substituted L-nucleosides against 3TC-resistant HBV polymerase: a molecular modelling approach.
Antiviral chemistry & chemotherapy 2003;14(6):309-19.
2003: Lieven Stuyver; Tamara R McBrayer; Phillip M Tharnish; Abdalla E A Hassan; Chung (David) K. Chu; Krzysztof W Pankiewicz; Kyochi A Watanabe; Ray F Schinazi; Michael J Otto
Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites.
Journal of virology 2003;77(19):10689-94.
2003: Abdalla E A Hassan; Balakrina S Pai; Stefania Lostia; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Kyoichi A Watanabe
Synthesis and antiviral evaluation of 2',3'-dideoxy-2'-fluoro-3'- C-hydroxymethyl-beta-D-arabinofuranosyl pyrimidine nucleosides.
Nucleosides, nucleotides & nucleic acids 2003;22(5-8):891-4.
2003: Junxing Shi; Judy S Mathew; Phillip M Tharnish; Suguna Rachakonda; S Balakrishna Pai; Marjorie Adams; Jason Grier; Karen Gallagher; Hangchun Zhang; Jing-Tao Wu; Guoen Shi; Romas Geleziunas; Susan Erickson-Viitanen; Lieven Stuyver; Michael J Otto; Kyoichi A Watanabe; Ray F Schinazi
N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity.
Antiviral chemistry & chemotherapy 2003;14(2):81-90.
2003: Lieven Stuyver; Tony Whitaker; Tamara R McBrayer; Brenda I Hernandez-Santiago; Stefania Lostia; Phillip M Tharnish; Mangala Ramesh; Chung (David) K. Chu; Robert Jordan; Junxing Shi; Suguna Rachakonda; Kyoichi A Watanabe; Michael J Otto; Ray F Schinazi
Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture.
Antimicrobial agents and chemotherapy 2003;47(1):244-54.
2002: Lieven Stuyver; Stefania Lostia; Marjorie Adams; Judy S Mathew; Balakrishna S Pai; Jason Grier; Phillip M Tharnish; Yongseok Choi; Youhoon Chong; Hyunah Choo; Chung (David) K. Chu; Michael J Otto; Ray F Schinazi
Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.
Antimicrobial agents and chemotherapy 2002;46(12):3854-60.
2002: Lieven Stuyver; Stefania Lostia; Steven E Patterson; Jeremy L Clark; Kyoichi A Watanabe; Michael J Otto; Krzysztof W Pankiewicz
Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Antiviral chemistry & chemotherapy 2002;13(6):345-52.
2002: Ray F Schinazi; John Mellors; Holly Bazmi; Sharon Diamond; Sena Garber; Karen Gallagher; Romas Geleziunas; Ronald Klabe; James Michael Pierce; Marlene Rayner; Jing-Tao Wu; Hangchun Zhang; Jennifer Hammond; Lee Bacheler; Douglas J Manion; Michael J Otto; Lieven Stuyver; George L Trainor; Dennis C Liotta; Susan Erickson-Viitanen
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.
Antimicrobial agents and chemotherapy 2002;46(5):1394-401.
2001: P D Swenson; C Van Geyt; E Russell Alexander; H Hagan; J M Freitag-Koontz; S Wilson; Helene Norder; Lars O Magnius; Lieven Stuyver
Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA.
Journal of medical virology 2001;64(3):305-11.
2001: Kristien Van Vaerenbergh; L Debaisieux; Nancy De Cabooter; C Declercq; Koenraad Desmet; Katrien Fransen; Bart Maes; Denise Marissens; K Miller; Gaëtan Muyldermans; S Sprecher; Lieven Stuyver; Dolores Vaira; Chris Verhofstede; Georges Zissis; Marc Van Ranst; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
Antiviral therapy 2001;6(1):63-70.
2001: Lieven Stuyver; S A Locarnini; Anna S F Lok; D D Richman; W F Carman; J L Dienstag; Ray F Schinazi
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.
Hepatology (Baltimore, Md.) 2001;33(3):751-7.
2001: Ray F Schinazi; S Schlueter-Wirtz; Lieven Stuyver
Early detection of mixed mutations selected by antiretroviral agents in HIV-infected primary human lymphocytes.
Antiviral chemistry & chemotherapy 2001;12 Suppl 1():61-5.
2000: S Nafa; S Ahmed; D Tavan; Christian Pichoud; F Berby; Lieven Stuyver; M Johnson; P Merle; H Abidi; Christian Trépo; Fabien Zoulim
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Hepatology (Baltimore, Md.) 2000;32(5):1078-88.
2000: Françoise Lunel; J F Cadranel; Michel Rosenheim; Richard Dorent; Vincent Di Martino; Christopher Payan; C Fretz; J J Ghoussoub; Brigitte Bernard; B Dumont; M Perrin; I Gandjbachkh; Jean-Marie Huraux; Lieven Stuyver; Pierre Opolon
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival.
Gastroenterology 2000;119(4):1064-74.
2000: C Grandjacques; Pierre Pradat; Lieven Stuyver; Michèle Chevallier; Philippe Chevallier; Christian Pichoud; Mireille Maisonnas; Christian Trépo; Fabien Zoulim
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.
Journal of hepatology 2000;33(3):430-9.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; J Albert; C A Boucher; Bonaventura Clotet; Marco Floridia; J Gerstoft; B Hejdeman; C Nielsen; Christophe Pannecouque; L Perrin; Maria F Pirillo; Lidia Ruiz; Jean-Claude Schmit; F Schneider; A Schoolmeester; R Schuurman; Hans-Jürgen Stellbrink; Lieven Stuyver; Jan van Lunzen; Barbara Van Remoortel; Eric Van Wijngaerden; STEFANO VELLA; Myriam Witvrouw; S Yerly; Erik De Clercq; J Destmyer; Anne-Mieke Vandamme
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Antimicrobial agents and chemotherapy 2000;44(8):2109-17.
2000: T Puig; Mayte Pérez-Olmeda; A Rubio; Lidia Ruiz; Carlos Briones; J M Franco; M Gómez-Cano; Lieven Stuyver; L Zamora; C Alvarez; Manuel Leal; Bonaventura Clotet; V Soriano
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.
AIDS (London, England) 2000;14(6):727-32.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; Eric Van Wijngaerden; Jean-Claude Schmit; F Schneider; Lidia Ruiz; Bonaventura Clotet; Chris Verhofstede; Filip Van Wanzeele; Gaëtan Muyldermans; P Simons; Lieven Stuyver; Philippe Hermans; C Evans; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.
AIDS research and human retroviruses 2000;16(6):529-37.
2000: Christian Pichoud; F Berby; Lieven Stuyver; M A Petit; Christian Trépo; Fabien Zoulim
Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.
Journal of hepatology 2000;32(2):307-16.
2000: Lieven Stuyver; C Van Geyt; Sija De Gendt; G Van Reybroeck; F Zoulim; G Leroux-Roels; Rudi Rossau
Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.
Journal of clinical microbiology 2000;38(2):702-7.
2000: Lieven Stuyver; Sija De Gendt; C Van Geyt; F Zoulim; M Fried; Ray F Schinazi; Rudi Rossau
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.
The Journal of general virology 2000;81(Pt 1):67-74.
1999: Sheila A Teles; Regina M B Martins; Bart Vanderborght; Lieven Stuyver; Ana Maria Coimbra Gaspar; Clara F T Yoshida
Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients.
Artificial organs 1999;23(12):1074-8.
1999: Kristel Van Laethem; Koen A De Smet; Jean-Claude Schmit; S Sprecher; Philippe Hermans; V De Vroey; R Schuurman; Thomas Harrer; Myriam Witvrouw; Eric Van Wijngaerden; Lieven Stuyver; Marc Van Ranst; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations.
Journal of acquired immune deficiency syndromes (1999) 1999;22(2):107-18.
1999: Rodrigo M Brindeiro; Bart Vanderborght; Elena Caride; L Correa; R M Oravec; O Berro; Lieven Stuyver; Amilcar Tanuri
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.
Antimicrobial agents and chemotherapy 1999;43(7):1674-80.
1999: Lieven Stuyver; Sija De Gendt; Jean-François Cadranel; C Van Geyt; G Van Reybroeck; R Dorent; I Gandjbachkh; Michel Rosenheim; Frédéric Charlotte; Pierre Opolon; Jean-Marie Huraux; Françoise Lunel
Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus.
Hepatology (Baltimore, Md.) 1999;29(6):1876-83.
1998: Jean-Claude Schmit; Lidia Ruiz; Lieven Stuyver; Kristel Van Laethem; I Vanderlinden; T Puig; Rudi Rossau; Jan Desmyter; Erik De Clercq; Bonaventura Clotet; Anne-Mieke Vandamme
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.
Journal of virological methods 1998;73(1):77-82.
1998: D Jeannel; C Fretz; Y Traore; N Kohdjo; A Bigot; E Pê Gamy; G Jourdan; K Kourouma; Geert Maertens; F Fumoux; JJ Fournel; Lieven Stuyver
Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.
Journal of medical virology 1998;55(2):92-7.
1998: Françoise Lunel; Lieven Stuyver; Christian Brechot; Geert Maertens
[Update on hepatitis C virus: its variability and the implications].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1998;5(2):147-65.
1998: Linda Blitz; Flor H Pujol; P D Swenson; Leticia Porto; Ricardo Atencio; M Araujo; Luciana Costa; D C Monsalve; Jaime R Torres; Howard A Fields; S Lambert; C Van Geyt; Helene Norder; Lars O Magnius; José M Echevarría; Lieven Stuyver
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela.
Journal of clinical microbiology 1998;36(3):648-51.
1998: B Robertson; G Myers; C Howard; T Brettin; Jens Bukh; B Gaschen; Takashi Gojobori; Geert Maertens; M Mizokami; Omana V Nainan; S Netesov; K Nishioka; Tadasu Shin-i; P Simmonds; D Smith; Lieven Stuyver; A Weiner
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy.
Archives of virology 1998;143(12):2493-503.
1997: Tae-Wook Chun; Lieven Stuyver; SB Mizell; Linda Ehler; Jo Ann M Mican; Michael Baseler; A L Lloyd; M A Nowak; Anthony Fauci
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(24):13193-7.
1997: Leen-Jan van Doorn; K van Hoek; G de Martinoff; F Bosman; Lieven Stuyver; T Kos; I Frantzen; P Sillekens; Geert Maertens; Wim Quint
Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees.
Journal of medical virology 1997;52(4):441-50.
1997: Hafida Khorsi; Sandrine Castelain; A Wyseur; Jacques Izopet; Valérie Canva; A Rombout; Dominique Capron; Jean-Pierre Capron; Françoise Lunel; Lieven Stuyver; Gilles Duverlie
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients.
Journal of hepatology 1997;27(1):72-7.
1997: Lieven Stuyver; A Wyseur; A Rombout; joost louwagie; T Scarcez; Chris Verhofstede; D Rimland; Ray F Schinazi; Rudi Rossau
Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.
Antimicrobial agents and chemotherapy 1997;41(2):284-91.
1996: S Magrin; Antonio Craxi; Carmelo Fabiano; L Marino; G Fiorentino; Oreste Lo Iacono; R Volpes; Vito Di Marco; Piero Luigi Almasio; A Vaccaro; MS Urdea; J C Wilber; Celestino Bonura; Fabrizio Gianguzza; V Capursi; S Filiberti; Lieven Stuyver; Luigi Pagliaro
HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
Journal of hepatology 1996;25(5):583-90.
1996: Lieven Stuyver; A Wyseur; W van Arnhem; F Hernandez; Geert Maertens
Second-generation line probe assay for hepatitis C virus genotyping.
Journal of clinical microbiology 1996;34(9):2259-66.
1996: Lieven Stuyver; C Fretz; C Esquivel; A Boudifa; D Jaulmes; Nabih Azar; Françoise Lunel; Geert Leroux-Roels; Geert Maertens; J J Fournel
Hepatitis C virus (HCV) genotype analysis in apparently healthy anti-HCV-positive Parisian blood donors.
Transfusion 1996;36(6):552-8.
1996: Lieven Stuyver; H Claeys; A Wyseur; W Van Arnhem; Hans De Beenhouwer; S Uytendaele; J Beckers; D Matthijs; Geert Leroux-Roels; Geert Maertens; M De Paepe
Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission.
Kidney international 1996;49(3):889-95.
1996: Geert Leroux-Roels; C A Esquivel; Robert DeLeys; Lieven Stuyver; A Elewaut; Jan Philippé; Isabelle Desombere; J Paradijs; Geert Maertens
Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
Hepatology (Baltimore, Md.) 1996;23(1):8-16.
1995: C Fretz; D Jeannel; Lieven Stuyver; V Hervé; Françoise Lunel; A Boudifa; Claire Mathiot; Guy de Thé; J J Fournel
HCV infection in a rural population of the Central African Republic (CAR): evidence for three additional subtypes of genotype 4.
Journal of medical virology 1995;47(4):435-7.
1995: Jean-Michel Pawlotsky; Françoise Darthuy; Jocelyne Rémiré; C Pellet; L Udin; Lieven Stuyver; Françoise Roudot-Thoraval; Christophe Duvoux; Catherine Douvin; Ariane Mallat
Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Journal of medical virology 1995;47(3):285-91.
1995: Lieven Stuyver; A Wyseur; W van Arnhem; Françoise Lunel; P Laurent-Puig; Jean-Michel Pawlotsky; Bernhard Kleter; Leda Bassit; J Nkengasong; Leen-Jan van Doorn
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.
Virus research 1995;38(2-3):137-57.
1995: G E Kleter; Leen-Jan van Doorn; Lieven Stuyver; Geert Maertens; Johannes T Brouwer; Solko W Schalm; Rudolf Heijtink; Wim Quint
Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western Europe.
Journal of medical virology 1995;47(1):35-42.
1995: Carlo Giannini; Valérie Thiers; J B Nousbaum; Lieven Stuyver; Geert Maertens; Christian Bréchot
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.
Journal of hepatology 1995;23(3):246-53.
1995: Leen-Jan van Doorn; G E Kleter; Lieven Stuyver; Geert Maertens; Johannes T Brouwer; Solko W Schalm; Rudolf Heijtink; Wim Quint
Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries.
The Journal of general virology 1995;76 ( Pt 7)():1871-6.
1995: Jean-Michel Pawlotsky; L Tsakiris; Françoise Roudot-Thoraval; C Pellet; Lieven Stuyver; J Duval; Daniel Dhumeaux
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.
The Journal of infectious diseases 1995;171(6):1607-10.
1995: P Laurent-Puig; E Dussaix; C Altman; C Laval; Lieven Stuyver; J C Wilber; G Babany; S Chopineau; P Bedossa; I Brocheriou
Host and viral characteristics affecting the response to interferon therapy in chronic hepatitis C.
European journal of gastroenterology & hepatology 1995;7(4):335-40.
1994: Lieven Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; Geert Maertens
Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(21):10134-8.
1994: Lieven Stuyver; W van Arnhem; A Wyseur; Geert Maertens
Cloning and phylogenetic analysis of the core, E2, and NS3/NS4 regions of the hepatitis C virus type 5a.
Biochemical and biophysical research communications 1994;202(3):1308-14.
1994: Leen-Jan van Doorn; Bernhard Kleter; Lieven Stuyver; Geert Maertens; H Brouwer; Solko W Schalm; Rudolf Heijtink; Wim Quint
Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles.
Journal of hepatology 1994;21(1):122-9.
1993: Lieven Stuyver; Rudi Rossau; A Wyseur; M Duhamel; Bart Vanderborght; H Van Heuverswyn; Geert Maertens
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.
The Journal of general virology 1993;74 ( Pt 6)():1093-102.
1993: Lieven Stuyver; W Van Arnhem; A Wyseur; Robert DeLeys; Geert Maertens
Analysis of the putative E1 envelope and NS4a epitope regions of HCV type 3.
Biochemical and biophysical research communications 1993;192(2):635-41.
1993: Wim Van Hul; Guy Van Camp; Lieven Stuyver; Jean-Maurice Delabar; Melvin G McInnis; AC Warren; S E Antonarakis; Christine Van Broeckhoven
A contiguous physical map of the pericentromeric region of chromosome 21q between D21Z1 and D21S13E.
Genomics 1993;15(3):626-30.